UPPSALA, Sweden - Senzime AB (publ), a global leader in precision-based patient monitoring, today announced the expanded clinical use of its TetraGraph® system in electroconvulsive therapy (ECT), a...

Source disclosure

This is a source-linked briefing. Read the original report from Finanznachrichten.de .